Search research articles
Contact Us
Filters
Showing results (31-40 of 98) with videos related to
Page
of 10
Sort By:
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
April 8, 2016
[Current guidelines in dermatology : A selection of clinically relevant recommendations]
A Nast, S Rosumeck, R Erdmann, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 8, 2020
Immunogenicity of biologic therapies in psoriasis: Myths, facts and a suggested approach
T Tsakok, T Rispens, P Spuls, et al.
The British Journal of Dermatology
|
October 21, 2017
Introducing the new Evidence-Based Dermatology section
C Flohr, K Abuabara, F Bath-Hextall, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 27, 2016
The impact of adverse reactions to injectable filler substances on quality of life: results from the Berlin Injectable Filler Safety (IFS) - study
D Düker, R Erdmann, V Hartmann, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 19, 2014
Risk of complications due to anticoagulation during dermatosurgical procedures: a systematic review and meta-analysis
A Nast, H Ernst, S Rosumeck, et al.
The British Journal of Dermatology
|
August 4, 2017
Time, Psoriasis Area and Severity Index and Dermatology Life Quality Index of patients with psoriasis who drop out of clinical trials on etanercept because of lack of efficacy: a pooled analysis from 10 clinical trials
A Nast, M Dilleen, W Liyanage, et al.
Molecular Pharmacology
|
January 28, 2009
A cytochrome P450-derived epoxygenated metabolite of anandamide is a potent cannabinoid receptor 2-selective agonist
Natasha T Snider, James A Nast, Laura A Tesmer, et al.
The British Journal of Dermatology
|
October 18, 2013
Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials
J Schmitt, S Rosumeck, G Thomaschewski, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
March 5, 2021
[Current dermatology guidelines in Germany and Europe : A selection of clinically relevant recommendations]
A Nast, R N Werner, C Dressler, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 10, 2015
Methods and Results Report - Evidence and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis -International League of Dermatological Societies in cooperation with the European Dermatology Forum
R N Werner, A Jacobs, S Rosumeck, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 98) with videos related to
Sort By:
Page
of 10
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
April 8, 2016
[Current guidelines in dermatology : A selection of clinically relevant recommendations]
A Nast, S Rosumeck, R Erdmann, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 8, 2020
Immunogenicity of biologic therapies in psoriasis: Myths, facts and a suggested approach
T Tsakok, T Rispens, P Spuls, et al.
The British Journal of Dermatology
|
October 21, 2017
Introducing the new Evidence-Based Dermatology section
C Flohr, K Abuabara, F Bath-Hextall, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 27, 2016
The impact of adverse reactions to injectable filler substances on quality of life: results from the Berlin Injectable Filler Safety (IFS) - study
D Düker, R Erdmann, V Hartmann, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 19, 2014
Risk of complications due to anticoagulation during dermatosurgical procedures: a systematic review and meta-analysis
A Nast, H Ernst, S Rosumeck, et al.
The British Journal of Dermatology
|
August 4, 2017
Time, Psoriasis Area and Severity Index and Dermatology Life Quality Index of patients with psoriasis who drop out of clinical trials on etanercept because of lack of efficacy: a pooled analysis from 10 clinical trials
A Nast, M Dilleen, W Liyanage, et al.
Molecular Pharmacology
|
January 28, 2009
A cytochrome P450-derived epoxygenated metabolite of anandamide is a potent cannabinoid receptor 2-selective agonist
Natasha T Snider, James A Nast, Laura A Tesmer, et al.
The British Journal of Dermatology
|
October 18, 2013
Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials
J Schmitt, S Rosumeck, G Thomaschewski, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
March 5, 2021
[Current dermatology guidelines in Germany and Europe : A selection of clinically relevant recommendations]
A Nast, R N Werner, C Dressler, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 10, 2015
Methods and Results Report - Evidence and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis -International League of Dermatological Societies in cooperation with the European Dermatology Forum
R N Werner, A Jacobs, S Rosumeck, et al.
Page
of 10